Riverview Capital Advisers’s Labcorp LH Stock Holding History

Riverview Capital Advisers’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Buy	6,922 +17	+0.2%	+$4.6K	0.62%	35
2025 Q4	$1.73M	Hold	6,905	–	–	0.52%	42
2025 Q3	$1.98M	Sell	6,905 -499	-7%	-$134K	0.57%	44
2025 Q2	$1.94M	Sell	7,404 -596	-7%	-$145K	0.56%	49
2025 Q1	$1.86M	Hold	8,000	–	–	0.59%	44
2024 Q4	$1.83M	Hold	8,000	–	–	0.55%	44
2024 Q3	$1.79M	Hold	8,000	–	–	0.55%	41
2024 Q2	$1.63M	Hold	8,000	–	–	0.55%	39
2024 Q1	$1.75M	Sell	8,000 -84	-1%	-$18.5K	0.6%	39
2023 Q4	$1.84M	Hold	8,084	–	–	0.71%	34
2023 Q3	$1.63M	Sell	8,084 -1,326	-14%	-$280K	0.72%	36
2023 Q2	$1.95M	Buy	9,410 +98	+1%	+$19K	0.86%	28
2023 Q1	$1.84M	Hold	9,312	–	–	0.79%	32
2022 Q4	$1.88M	Hold	9,312	–	–	1.01%	24
2022 Q3	$1.64M	Hold	9,312	–	–	1.03%	29
2022 Q2	$1.87M	Hold	9,312	–	–	1.04%	29
2022 Q1	$2.11M	Hold	9,312	–	–	0.97%	33
2021 Q4	$2.51M	Buy	+9,312	New	+$2.31M	1.12%	28

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverview Capital Advisers's LH Position: Q1 2026 in Review

Riverview Capital Advisers increased its Labcorp (LH) stake by 0.25% in Q1 2026, buying an estimated $4.6K and bringing the position to 6,922 shares worth $1.85M. The position accounts for 0.62% of the portfolio, ranked #35.

Riverview Capital Advisers first reported a position in LH in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.51M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Riverview Capital Advisers held 6,922 shares of Labcorp worth $1.85M as of Q1 2026.
Riverview Capital Advisers bought 17 Labcorp shares in Q1 2026, an estimated $4.6K.
Labcorp made up 0.62% of Riverview Capital Advisers's portfolio in Q1 2026, its #35 holding.
Riverview Capital Advisers first reported a position in Labcorp in Q4 2021 and has held it in 18 quarters since.
Riverview Capital Advisers's Labcorp position peaked at $2.51M in Q4 2021.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Riverview Capital Advisers's 13F filing for Q1 2026, filed 14 May 2026.